Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Immune Thrombocytopenic Purpura
Trial Locations (22)

6020

Research Site, Innsbruck

8000

Research Site, Bruges

8700

Research Site, Leoben

9000

Research Site, Ghent

11527

Research Site, Athens

12200

Research Site, Berlin

24100

Research Site, Kalamata

28031

Research Site, Madrid

28041

Research Site, Madrid

28222

Research Site, Majadahonda

33604

Research Site, Pessac

34395

Research Site, Montpellier

54636

Research Site, Thessaloniki

75571

Research Site, Paris

87042

Research Site, Limoges

94010

Research Site, Créteil

96317

Research Site, Kronach

2545 CH

Research Site, The Hague

5504 DB

Research Site, Veldhoven

05004

Research Site, Ávila

LE1 5WW

Research Site, Leicester

E1 1BB

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY